Pantoprazol Ever Pharma (Pantoprazole)

Pantoprazole, the active ingredient in Pantoprazol Ever Pharma, is a Proton Pump Inhibitor presented as a intravenous solution for intravenous use. It reduces gastric acid secretion and is used in the treatment of acid‑related gastrointestinal conditions in adults.

GNH USA supplies Pantoprazol Ever Pharma as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide.

Pantoprazol Ever Pharma is a proton pump inhibitor that acts on the gastric acid secretion pathway. - Gastro‑esophageal reflux disease (GERD): provides symptomatic relief and promotes healing of erosive esophagitis. - Peptic ulcer disease: supports ulcer healing and reduces risk of recurrence. - Zollinger‑Ellison syndrome: controls excessive gastric acid production associated with the condition.

Adverse reactions reported with pantoprazole intravenous administration are generally mild to moderate.

Common Side Effects: - Headache: mild and transient. - Diarrhoea: loose stools without blood. - Nausea: occasional feeling of queasiness. - Abdominal pain: mild discomfort in the upper abdomen. - Injection site reactions: redness or mild swelling at the infusion site.

Serious or Rare Side Effects: - Severe hypersensitivity: rash, itching, swelling, or anaphylaxis. - Clostridioides difficile infection: persistent watery diarrhoea. - Acute interstitial nephritis: sudden decrease in kidney function. - Hepatic dysfunction: elevated liver enzymes or jaundice. - Thromboembolic events: deep vein thrombosis or pulmonary embolism.

When using Pantoprazol Ever Pharma, consider the following safety measures: - Renal impairment: dose adjustment may be needed in severe kidney dysfunction. - Hepatic impairment: monitor liver function tests in patients with liver disease. - Elderly patients: observe for increased sensitivity to side effects. - Concomitant use with NSAIDs: higher risk of gastrointestinal bleeding. - Pregnancy and lactation: weigh benefits against potential risks; use only if clearly indicated. - Store at below 25°C: keep in the original container, protect from moisture and light.

Pantoprazol Ever Pharma may interact with several medicines that share metabolic pathways or affect gastric pH.

Major Interactions (Avoid): - Ketoconazole oral suspension: reduced absorption due to increased gastric pH. - Atazanavir: markedly decreased plasma concentrations. - Clopidogrel: diminished antiplatelet effect.

Moderate Interactions (Monitor Closely): - Warfarin: potential alteration of INR values. - Methotrexate: increased serum levels, especially at high doses. - Digoxin: modest increase in serum concentration.